Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Urolithiasis
Published in: Urolithiasis 2/2006

01-04-2006 | Article

Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment

Author: K. Sarica

Published in: Urolithiasis | Issue 2/2006

Login to get access

Abstract

Pediatric urolithiasis is an endemic disease in certain parts of the world, namely Turkey and the Far East. As a recurrent pathology which may reveal functional as well and morphologic changes in the urinary tract, environmental factors together with urogenital abnormalities should be evaluated thoroughly in each patient. The aims of management should be complete clearance of stones, treatment of urinary tract infections, preservation of renal function and prevention of stone recurrence. In addition to certain minimally invasive stone removal procedures, treatment of pediatric urolithiasis requires a detailed metabolic evaluation in all patients on an individual basis. Obstructive pathologies have to be corrected immediately and children with a positive family history should be followed carefully with respect to a high likelihood of stone re-growth and recurrence. Although specific management of each metabolic abnormality seems to be the key factor in the medical management of stone disease, as general advice each child should be forced to adequate fluid intake which will reveal the urine volume increase in accordance with the body mass index. Moreover, medical therapeutic agents which increase urine citrate levels should be encouraged.
Literature
1.
2.
Milliner DS, Murphy ME (1993) Urolithiasis in pediatric patients. Mayo Clin Proc 68:241–248PubMed
3.
Stapleton FB, McKay CP, Noe HN (1987) Urolithiasis in children: the role of hypercalciuria. Pediatr Ann 16:980–992PubMed
4.
Choi H, Snyder III HM, Duckett JW (1987) Urolithiasis in childhood: current management. J Pediatr Surg 72:158–164CrossRef
5.
Gearhart JR, Herzberg GZ, Jeffs RD (1991) Childhood urolithiasis: experiences and advances. Pediatrics 87:445–450PubMed
6.
Polinsky MS, Kaiser BA, Baluarte HJ (1987) Urolithiasis in childhood. Pediatr Clin North Am;84:683–710
7.
Ryall RL (1996) Glycosaminoglycans, proteins, and stone formation: adult themes and child’s play. Pediatr Nephrol 10:656–666CrossRefPubMed
8.
Parks JH, Coward M, Coe FL (1997) Correspondence between stone composition and urine saturation in nephrolithiasis. Kidney Int 51:894–900PubMedCrossRef
9.
Battino BS, DeFoor W, Coe F, Tackett L, Erhard M, Wacksman J et al (2002) Metabolic evaluation of children with urolithiasis: are adult references for supersaturation appropriate? J Urol 168:2568–2571CrossRefPubMed
10.
Kruse K, Kracht U, Kruse U (1984) Reference values for urinary calcium excretion and screening for hypercalciuria in children and adolescents. Eur J Pediatr 143:23–31CrossRef
11.
DeSanto NG, DiIorio B, Capasso G, Paduano C, Stamler R, Langman CB et al (1992) Population based data on urinary excretion of calcium, magnesium, oxalate, phosphate and uric acid in children from Cimitile (southern Italy). Pediatr Nephrol 6:149–157CrossRefPubMed
12.
Ghazali S, Barratt TM (1974) Urinary excretion of calcium and magnesium in children. Arch Dis Child 45:97–101
13.
Stapleton FB, Noe HN, Roy S III, Jerkins GR (1982) Hypercalciuria in children with urolithiasis. Am J Dis Child 136:675–678PubMed
14.
Stapleton FB, Noe HN, Jerkins GR, Roy S III (1982) Urinary excretion of calcium following an oral calcium-loading test in healthy children. Pediatrics 69:594–597PubMed
15.
16.
Stapleton FB (1990) Idiopathic hypercalciuria: association with isolated hematuria and risk for urolithiasis in children. Kidney Int 37:807–811PubMedCrossRef
17.
Dent CE, Friedman M (1964) Hypercalciuric rickets associated with renal tubular damage. Arch Dis Child 39:240–249PubMed
18.
Igarashi T, Hayakawa H, Shiraga H, Kawato H, Yan K, Kawaguchi H et al (1995) Hypercalciuria and nephrocalcinosis in patients with idiopathic low molecular weight proteinuria in Japan. Nephron 69:242–247PubMedCrossRef
19.
Furth SL, Casey JC, Pyzik PL, New AM, Docimo SG, Vining EPG et al (2000) Risk factors for urolithiasis in children on the ketogenic diet. Pediatr Nephrol 15:125–8CrossRefPubMed
20.
Herzberg GZ, Fivush BA, Kinsman SL, Gearhart JP (1990) Urolithiasis associated with the ketogenic diet. J Pediatr 117:743–745PubMedCrossRef
21.
Asplin JR (2002) Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin N Am 31:927–949CrossRef
22.
Pietrow PK, Pope JC, Adams MC, Shyr Y, Brock III JW (2002) Clinical outcome of pediatric stone disease. J Urol 167:670–673CrossRefPubMed
23.
24.
Cohen TD, Ehreth J, King LR, Preminger GM (1996) Pediatric urolithiasis: medical and surgical management. Urology 47(3):292–305CrossRefPubMed
25.
Milliner DS, Murphy ME (1993) Urolithiasis in pediatric patients. Mayo Clin Proc 68:241–244PubMed
26.
Erbağcı A, Erbağcı BA, Yılmaz M, Yağcı F, Tarakçıoğlu M, Yurtseven C, Köylüoğlu O, Sarıca K (2003) Pediatric urolithiasis. Scand J Urol Nephrol 37:127–133
27.
Rizvi SAH, Naqvi SAA, Hussain Z, Hashmi A, Hussain M, Zafar MN, Sultan S, Mehdi H (2002) Pediatric urolithiasis: developing nation perspectives. J Urol 168:1522–1525CrossRefPubMed
28.
Tefekli A, Esen T, Ziylan O, Erol B, Armağan A, Ander H, Akıncı M (1993) Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: Is there any difference? Urol Int 70:273–277CrossRef
29.
Noe HN (2000) Hypercalciuria and pediatric stone recurrences with and without structural abnormalities. J Urol part 2 164:1094–1096
30.
Diamond DA, Menon M, Lee PH et al (1989) Etiological factors in pediatric stone recurrence. J Urol part 2 142:606–608
31.
Hoppe B, Jahnen A, Bach D, Hesse A (1997) Urinary calcium oxalate saturation in healthy infants and children. J Urol 158:557–559CrossRefPubMed
32.
Drach GW (1995) Metabolic evaluation of pediatric patients with stones. Urol Clin North Am 22:95–102PubMed
33.
Stapleton B (1996) Clinical approach to children with urolithiasis. Semin Urol 16(5):389–397
34.
Tekin A, Tekgül S, Atsu N, Şahin A, Özen H, Bakkaloğlu M (2000) A study of the etiology of idiopathic calcium urolithiasis in children. Hypocitraturia is the most important risk factor. J Urol 164:162–165CrossRefPubMed
35.
Perrone HC, dos Santos DR, Santos MV (1992) Urolithiasis in childhood: metabolic evaluation. Pediatr Nephrol 6:54–59CrossRefPubMed
36.
Pietrow PK, Pope JC, Adams MC, Shyr Y, Brock JW (2002) Clinical outcome of pediatric stone disease. J Urol 160:670–73
37.
Özokutan BH, Küçükaydın M, Gündüz Z et al (2000) Urolithiasis in childhood. Pediatr Surg Int 16:60–63CrossRefPubMed
38.
Soygur T, Akbay A, Kupeli S (2002) Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 16(3):149–152CrossRefPubMed
39.
Whalley NA, Meyers AM, Martins M, Margolius LP (1996) Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia. Br J Urol 78(1):10–14PubMed
40.
Pak CYC, Fuller C, Sakhaee K et al (1985) Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 134:11–14PubMed
41.
Barcelo B, Wahl O, Semitge E, Rousaud A, Pak CYC (1993) Randomized double-blind study on potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150:1761–1764PubMed
42.
Borghi L, Meschi T, Amato F, Briganti A, Navarini A, Giannini A (1996) Urine volume, water and recurrences in idiopathic calcium nephrolithiasis. A 5-year randomized prospective study. J Urol 155:839–843CrossRefPubMed
43.
Hoskin DH, Erickson SD, van der Berg CJ, Wilson DM, Smith LH (1983) The stone clinic effect in patients with idiopathic calcium nephrolithiasis. J Urol 13:1115–1118
44.
Tekin A, Tekgul S, Atsu N, Bakkaloglu M, Kendi S (2002) Oral potassium citrate treatment for idiopathic hypocitruria in children with calcium urolithiasis. J Urol 168(6):2572–2574CrossRefPubMed
45.
Stapleton FB, Kroovand RL (1996) Stones in childhood. In: Coe FL, Favres MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stones: medical and surgical management. Lippencott-Raven, Philadelphia, pp 1065–1080
46.
Cohen TD, Ehreth J, King LR, Preminger GM (1996) Pediatric urolithiasis: medical and surgical management. Urology 47(3):292–305CrossRefPubMed
47.
Asplin JR (2002) Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin N Am 31:927–949CrossRef
48.
Coulthard MG, Richardson J, Fleetwood A (1995) The treatment of cystinuria with captopril. Am J Kidney Dis 25:661–662PubMed
Metadata
Title
Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment
Author
K. Sarica
Publication date
01-04-2006
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 2/2006
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-005-0018-0

Other articles of this Issue 2/2006

Urolithiasis 2/2006 Go to the issue

Article

Supersaturation and renal precipitation: the key to stone formation?

Article

Management of lower pole renal calculi: shock wave lithotripsy versus percutaneous nephrolithotomy versus flexible ureteroscopy

Article

Acid–base metabolism: implications for kidney stosne formation

Article

Shockwave lithotripsy and endourological stone treatment in children

Article

Is prevention of stone recurrence financially worthwhile?

Article

Lithiasis in cystic kidney disease and malformations of the urinary tract